Sort

Search

01/12/2021 Clinical triage of patients on kidney replacement therapy presenting with COVID-19: an ERACODA registry analysis
Mitra, S, Jayanti, A, Vart, P, Coca, A, Gallieni, M, Ovrehus, MA, Midtvedt, K, Abd ElHafeez, S, Gandolfini, I, Buttner, S, Franssen, CFM, Hemmelder, MH, Canal C., Facundo C., ERACODA Collaborators. Clinical triage of patients on kidney replacement therapy presenting with COVID-19: an ERACODA registry analysis. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2021; 36(12)DOI:10.1093/ndt/gfab196. PMID:34129039. IF:7.186(Q1/2D).
01/12/2021 Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study
Siddiqi, ZA, Nowak, RJ, Mozaffar, T, O'Brien, F, Yountz, M, Patti, F, Illa I., Cortés-Vicente E., Díaz-Manera J., Querol L.A., Rojas-García R., Vidal-Fernandez N., Nye, Joan L.. Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study. MUSCLE & NERVE. 2021; 64(6)DOI:10.1002/mus.27422. PMID:34590717. IF:3.852(Q2/5D).
01/12/2021 Rationale and Design of the Efficacy of a Standardized Diuretic Protocol in Acute Heart Failure Study
Dauw, J, Lelonek, M, Zegri-Reiriz, I, Paredes-Paucar, CP, Zara, C, George, V, Cobo-Marcos, M, Knappe, D, Shchekochikhin, D, Lekhakul, A, Klincheva, M, Frea, S, Miro, O, Barker, D, Borbely, A, Nasr, S, Doghmi, N, de la Espriella, R, Singh, JS, Bovolo, V, Fialho, I, Ross, NT, van den Heuvel, M, Benkouar, R, Findeisen, H, Alhaddad, IA, Al Balbissi, K, Barge-Caballero, G, Ghazi, AM, Bruckers, L, Martens, P, Mullens, W. Rationale and Design of the Efficacy of a Standardized Diuretic Protocol in Acute Heart Failure Study. ESC Heart Failure. 2021; 8(6)DOI:10.1002/ehf2.13666. PMID:34708555. IF:3.612(Q2/5D).
01/12/2021 Multi-Centre, Multi-Vendor and Multi-Disease Cardiac Segmentation: The M&Ms Challenge
Campello, VM, Gkontra, P, Izquierdo, C, Martin-Isla, C, Sojoudi, A, Full, PM, Maier-Hein, K, Zhang, Y, He, ZQ, Ma, J, Parreno, M, Albiol, A, Kong, FW, Shadden, SC, Acero, JC, Sundaresan, V, Saber, M, Elattar, M, Li, HW, Menze, B, Khader, F, Haarburger, C, Scannell, CM, Veta, M, Carscadden, A, Punithakumar, K, Liu, X, Tsaftaris, SA, Huang, XQ, Yang, X, Li, L, Zhuang, XH, Vilades, D, Descalzo, ML, Guala, A, La Mura, L, Friedrich, MG, Garg, R, Lebel, J, Henriques, F, Karakas, M, Cavus, E, Petersen, SE, Escalera, S, Segui, S, Rodriguez-Palomares, JF, Lekadir, K. Multi-Centre, Multi-Vendor and Multi-Disease Cardiac Segmentation: The M&Ms Challenge. IEEE TRANSACTIONS ON MEDICAL IMAGING. 2021; 40(12)DOI:10.1109/TMI.2021.3090082. PMID:34138702. IF:11.037(Q1/1D).
01/12/2021 Worldwide sedation strategies for atrial fibrillation ablation: current status and evolution over the last decade
Garcia, R, Waldmann, V, Vanduynhoven, P, Nesti, M, Figueiredo, MJD, Narayanan, K, Conte, G, Guerra, JM, Boveda, S, Duncker, D. Worldwide sedation strategies for atrial fibrillation ablation: current status and evolution over the last decade. EUROPACE. 2021; 23(12)DOI:10.1093/europace/euab154. PMID:34308973. IF:5.486(Q2/4D).
01/12/2021 Prevalence, mechanisms and impact of residual patency and device-related thrombosis following left atrial appendage occlusion: a computed tomography analysis
Agudelo, V, Millan, X, Li, CH, Moustafa, AH, Asmarats, L, Serra, A, Arzamendi, D. Prevalence, mechanisms and impact of residual patency and device-related thrombosis following left atrial appendage occlusion: a computed tomography analysis. EuroIntervention. 2021; 17(11)DOI:10.4244/EIJ-D-21-00320. PMID:34219668. IF:7.728(Q1/2D).
01/12/2021 ICD shock below the detection rate therapy zone-When appropriate is inadequate
Garcia-Hernando, V, Mendez-Zurita, F, Rodriguez-Font, E, Alonso-Martin, C, Guerra-Ramos, JM, Campos-Garcia, B, Moreno-Weidmann, Z, Benedicto, AM, Vinolas, X. ICD shock below the detection rate therapy zone-When appropriate is inadequate. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY. 2021; 32(12)DOI:10.1111/jce.15241. PMID:34532919. IF:2.942(Q3/6D).
01/12/2021 Dyslipidemia and aortic valve disease
Mata, P, Alonso, R, de Isla, LP, Badimon, L. Dyslipidemia and aortic valve disease. CURRENT OPINION IN LIPIDOLOGY. 2021; 32(6)DOI:10.1097/MOL.0000000000000794. PMID:34629429. IF:4.616(Q2/4D).
01/12/2021 One year of omega 3 polyunsaturated fatty acid supplementation does not reduce circulating prothrombotic microvesicles in elderly subjects after suffering a myocardial infarction
Chiva-Blanch, G, Bratseth, V, Laake, K, Arnesen, H, Solheim, S, Schmidt, EB, Badimon, L, Seljeflot, I. One year of omega 3 polyunsaturated fatty acid supplementation does not reduce circulating prothrombotic microvesicles in elderly subjects after suffering a myocardial infarction. CLINICAL NUTRITION. 2021; 40(12)DOI:10.1016/j.clnu.2021.10.007. PMID:34742136. IF:7.643(Q1/2D).
01/12/2021 Current Status of Genetic Counselling for Rare Diseases in Spain
Alvaro-Sanchez, S, Abreu-Rodriguez, I, Abuli, A, Serra-Juhe, C, Garrido-Navas, MD. Current Status of Genetic Counselling for Rare Diseases in Spain. Diagnostics. 2021; 11(12)DOI:10.3390/diagnostics11122320. PMID:34943558. IF:3.992(Q2/4D).
01/12/2021 Immunoparesis defined by heavy/light chain pair suppression in smoldering multiple myeloma shows initial isotype specificity and involves other isotypes in advanced disease
Isola, I, Moreno, DF, Moga, E, Mena, MP, Tovar, N, Rodriguez-Lobato, LG, Oliver-Caldes, A, Salgado, MC, Braso-Maristany, F, Yague, J, Cibeira, MT, Prat, A, Rosinol, L, Blade, J, de Larrea, CF. Immunoparesis defined by heavy/light chain pair suppression in smoldering multiple myeloma shows initial isotype specificity and involves other isotypes in advanced disease. ANNALS OF HEMATOLOGY. 2021; 100(12)DOI:10.1007/s00277-021-04653-2. PMID:34463804. IF:4.030(Q2/5D).
01/12/2021 Extracellular Vesicles in Pulmonary Fibrosis Models and Biological Fluids of Interstitial Lung Disease Patients: A Scoping Review
d'Alessandro, M, Bergantini, L, Bargagli, E, Vidal, S. Extracellular Vesicles in Pulmonary Fibrosis Models and Biological Fluids of Interstitial Lung Disease Patients: A Scoping Review. Life-Basel. 2021; 11(12)DOI:10.3390/life11121401. PMID:34947932. IF:3.253(Q2/5D).
01/12/2021 Characterization of the hypertriglyceridemic waist phenotype in patients with type 2 diabetes mellitus in Spain: an epidemiological study
Minambres, I, Sanchez-Hernandez, J, Cuixart, G, Sanchez-Pinto, A, Sarroca, J, Perez, A. Characterization of the hypertriglyceridemic waist phenotype in patients with type 2 diabetes mellitus in Spain: an epidemiological study. REVISTA CLINICA ESPANOLA. 2021; 221(10)DOI:10.1016/j.rce.2020.06.013. PMID:34839890. IF:3.064(Q2/5D).
01/12/2021 Therapeutic Potential of Emerging NAD plus -Increasing Strategies for Cardiovascular Diseases
Rotllan, N, Camacho, M, Tondo, M, Diarte-Anazco, EMG, Canyelles, M, Mendez-Lara, KA, Benitez, S, Alonso, N, Mauricio, D, Escola-Gil, JC, Blanco-Vaca, F, Julve, J. Therapeutic Potential of Emerging NAD plus -Increasing Strategies for Cardiovascular Diseases. Antioxidants. 2021; 10(12)DOI:10.3390/antiox10121939. PMID:. IF:7.675(Q1/1D).
01/12/2021 Advanced Quantitative Lipoprotein Characteristics Do Not Relate to Healthy Dietary Patterns in Adults from a Mediterranean Area
Rojo-Lopez, MI, Castelblanco, E, Real, J, Hernandez, M, Falguera, M, Amigo, N, Julve, J, Alonso, N, Franch-Nadal, J, Granado-Casas, M, Mauricio, D. Advanced Quantitative Lipoprotein Characteristics Do Not Relate to Healthy Dietary Patterns in Adults from a Mediterranean Area. Nutrients. 2021; 13(12)DOI:10.3390/nu13124369. PMID:34959921. IF:6.706(Q1/2D).
01/12/2021 Advanced lipoprotein parameters could better explain atheromatosis in non-diabetic chronic kidney disease patients
Bermudez-Lopez, M, Perpinan, H, Amigo, N, Castro, E, Alonso, N, Mauricio, D, Fernandez, E, Valdivielso, JM. Advanced lipoprotein parameters could better explain atheromatosis in non-diabetic chronic kidney disease patients. Clinical Kidney Journal. 2021; 14(12)DOI:10.1093/ckj/sfab113. PMID:34950470. IF:5.860(Q1/2D).
01/12/2021 Outstanding improvement of the advanced lipoprotein profile in subjects with new-onset type 1 diabetes mellitus after achieving optimal glycemic control
Castelblanco, E, Hernandez, M, Ortega, E, Amigo, N, Real, J, Granado-Casas, M, Minambres, I, Lopez, C, Lecube, A, Bermudez-Lopez, M, Alonso, N, Julve, J, Mauricio, D. Outstanding improvement of the advanced lipoprotein profile in subjects with new-onset type 1 diabetes mellitus after achieving optimal glycemic control. DIABETES RESEARCH AND CLINICAL PRACTICE. 2021; 182DOI:10.1016/j.diabres.2021.109145. PMID:34785302. IF:8.180(Q1/2D).
01/12/2021 Short-term foot complications in Charcot neuroarthropathy: A retrospective study in tertiary care centres in tertiary care centres in Spain (vol 65, pg 479, 2018)
Doria, M, Viade, J, Palomera, E, Perez, R, Llado, M, Costa, E, Huguet, T, Reverter, JL, Serra-Prat, M, Franch-Nadal, J, Mauricio, D. Short-term foot complications in Charcot neuroarthropathy: A retrospective study in tertiary care centres in tertiary care centres in Spain (vol 65, pg 479, 2018). Endocrinologia Diabetes y Nutricion. 2021; 68(10)DOI:10.1016/j.endinu.2021.10.002. PMID:. IF:1.833(Q4/9D).
01/12/2021 Incidence and characteristics of diabetic foot ulcers in subjects with type 2 diabetes in Catalonian primary care centres: An observational multicentre study
Bundo, M, Llussa, J, Serra, M, de la Iglesia, PP, Gimbert, RM, Real, J, Vlacho, B, Mata-Cases, M, Cos, X, Franch-Nadal, J, Mauricio, D. Incidence and characteristics of diabetic foot ulcers in subjects with type 2 diabetes in Catalonian primary care centres: An observational multicentre study. Primary Care Diabetes. 2021; 15(6)DOI:10.1016/j.pcd.2021.08.002. PMID:34419365. IF:2.567(Q3/6D).
01/12/2021 Resistance to first-generation somatostatin receptor ligands does not impair the results of gamma knife radiosurgery in acromegaly
Losa, M, Resmini, E, Barzaghi, LR, Albano, L, Bailo, M, Webb, SM, Mortini, P. Resistance to first-generation somatostatin receptor ligands does not impair the results of gamma knife radiosurgery in acromegaly. CLINICAL ENDOCRINOLOGY. 2021; 95(6)DOI:10.1111/cen.14547. PMID:34219264. IF:3.523(Q3/7D).